Search for: "Mylan Pharmaceuticals"
Results 21 - 40
of 738
Sorted by Relevance
|
Sort by Date
18 Oct 2009, 5:42 pm
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...] [read post]
20 Aug 2017, 7:14 am
Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. agree to pay $465 million to settle a lawsuit brought under the False Claims Act (FCA). [read post]
9 Dec 2021, 7:15 am
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
30 Jun 2011, 2:13 pm
Patent No. 7,915,307...This action relates to an Abbreviated New Drug Application ("ANDA") filed by Mylan Pharmaceuticals, Inc. with the U.S. [read post]
8 Nov 2021, 9:15 am
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
24 Oct 2008, 11:37 am
Swiss-drug major Novartis has filed a lawsuit in the US District Court for the District of New Jersey against Mylan Pharmaceuticals Inc. for infringement of Orange Book listed US Patent No. 5,354,772 (the ‘772 patent) for Lescol capsules, generically known as Fluvastatin Sodium. [read post]
12 Dec 2011, 9:59 pm
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
14 Apr 2022, 11:42 am
Author Karjis Sambrans Licence CC BY 2.0 Source Wikimedia CommonsJane LambertPatents Court (Mr Ian Karet) Neurim Pharmaceuticals (1991) Ltd another v Generics (UK) Ltd (T/A Viatris) and another [2021] EWHC 2897 (Pat) (29 Ort 2021)This was an application by Generics (UK) Limited and Mylan UK Healthcare Limited ("Mylan") for a stay of the expedited trial that had been ordered by Mr Justice Mellor [read post]
25 Aug 2017, 2:25 pm
(collectively, “Mylan”) have… The post Pharmaceutical Companies Agree to Pay $465 Million Settlement in EpiPen False Claims Act Lawsuit appeared first on TZ Legal - Fraud Fighters. [read post]
27 Sep 2019, 7:20 am
The Securities and Exchange Commission today announced charges against Pennsylvania-based pharmaceutical company Mylan N.V. for accounting and disclosure failures relating to a Department of Justice (DOJ) probe into whether Mylan overcharged Medicaid by…Read the Full Press ReleaseWant to talk to a securities lawyer? [read post]
17 Mar 2022, 9:06 pm
Mylan Pharmaceuticals Inc. [read post]
14 Feb 2019, 9:50 pm
RE38,551 challenged in inter partes review were not unpatentable for obviousness, in Mylan Pharmaceuticals Inc. v. [read post]
8 Aug 2013, 9:59 pm
Mylan Pharmaceuticals Inc. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
8 Nov 2021, 9:15 am
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
24 Dec 2018, 6:08 am
The CBS Evening News reported, Mylan Pharmaceuticals expanded its recall of blood pressure medications to include Valsartan-containing products. [read post]
17 Dec 2008, 5:54 am
The challenges to the '777 patent had been initiated by Defendants-Appellants Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc. [read post]
1 Jul 2020, 4:32 pm
Jane Lambert Court of Appeal (Lords Justices Floyd, Males and Arnold) Neurim Pharmaceuticals (1991) Ltd and another v Generics UK Ltd (t/a Mylan) and another [2020] EWCA Civ 793 (24 June 2020) This was an appeal by the claimants, Neurim Pharmaceuticals (1991) Ltd ("Neurim") and its exclusive licensee Flynn Pharma Ltd ("Flynn"), against Mr Justice Marcus Smith's refusal in Neurim [read post]
25 Aug 2017, 7:02 am
The Medicaid drug rebate requirements that Mylan allegedly sought to avoid were enacted by Congress to prevent drug manufacturers from gouging state Medicaid programs on prices for pharmaceuticals that are only available from a single source. [read post]
25 Aug 2017, 7:02 am
The Medicaid drug rebate requirements that Mylan allegedly sought to avoid were enacted by Congress to prevent drug manufacturers from gouging state Medicaid programs on prices for pharmaceuticals that are only available from a single source. [read post]
